A Phase 2a, Randomised, Double-Blind (3rd Party Open), Double-Dummy, Placebo And Active Controlled 5-Way Crossover Study To Assess The Bronchodilatory Action, Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04191834 In Asthmatic Patients.
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2013
At a glance
- Drugs PF 4191834; Zileuton
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Pfizer
- 24 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jul 2009 Actual end date (July 2009) added as reported by ClinicalTrials.gov.
- 15 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.